These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19450282)

  • 61. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
    Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
    Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sustained use of insecticide-treated curtains is not associated with greater circulation of drug-resistant malaria parasites, or with higher risk of treatment failure among children with uncomplicated malaria in Burkina Faso.
    Diallo DA; Sutherland C; Nebié I; Konaté AT; Ord R; Pota H; Roper C; Ilboudo-Sanogo E; Greenwood BM; Cousens SN
    Am J Trop Med Hyg; 2007 Feb; 76(2):237-44. PubMed ID: 17297030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations.
    Checchi F; Durand R; Balkan S; Vonhm BT; Kollie JZ; Biberson P; Baron E; Le Bras J; Guthmann JP
    Trans R Soc Trop Med Hyg; 2002; 96(6):664-9. PubMed ID: 12625147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13 years after cessation of chloroquine use in Msambweni, Kenya.
    Kiarie WC; Wangai L; Agola E; Kimani FT; Hungu C
    Malar J; 2015 Aug; 14():328. PubMed ID: 26296743
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular surveillance of chloroquine drug resistance markers (Pfcrt and Pfmdr1) among imported Plasmodium falciparum malaria in Qatar.
    Acharya A; Bansal D; Bharti PK; Khan FY; Abusalah S; Elmalik A; ElKhalifa M; Mohapatra PK; Mahanta J; Sehgal R; Singh N; Sultan AA
    Pathog Glob Health; 2018 Mar; 112(2):57-62. PubMed ID: 29125042
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Pcr-rflp genotyping of
    Ravaoarisoa É; Andrianaranjaka VHI; Ramanantsahala AD; Rakotomanga TA; Ralinoro F; Rakotosaona R; Randrianarivo RH; Rakoto DAD; Jeannoda V; Ratsimbasoa A
    Med Trop Sante Int; 2022 Jun; 2(2):. PubMed ID: 35919251
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum.
    Zakeri S; Afsharpad M; Kazemzadeh T; Mehdizadeh K; Shabani A; Djadid ND
    Am J Trop Med Hyg; 2008 Apr; 78(4):633-40. PubMed ID: 18385361
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.
    van den Broek IV; van der Wardt S; Talukder L; Chakma S; Brockman A; Nair S; Anderson TC
    Trop Med Int Health; 2004 Jun; 9(6):680-7. PubMed ID: 15189458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
    Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
    Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
    Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
    Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE; Alifrangis M; Khalil IF; Bygbjerg IC; Masuadi EM; Elbashir MI; Giha HA
    Malar J; 2007 Aug; 6():108. PubMed ID: 17686173
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic polymorphisms in Plasmodium falciparum chloroquine resistance genes, pfcrt and pfmdr1, in North Sulawesi, Indonesia.
    Reteng P; Vrisca V; Sukarno I; Djarkoni IH; Kalangi JA; Jacobs GE; Runtuwene LR; Eshita Y; Maeda R; Suzuki Y; Mongan AE; Warouw SM; Yamagishi J; Tuda J
    BMC Res Notes; 2017 Apr; 10(1):147. PubMed ID: 28376874
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
    Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.
    Bin Dajem SM; Al-Farsi HM; Al-Hashami ZS; Al-Sheikh AA; Al-Qahtani A; Babiker HA
    Am J Trop Med Hyg; 2012 May; 86(5):782-8. PubMed ID: 22556074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia.
    Golassa L; Enweji N; Erko B; Aseffa A; Swedberg G
    Malar J; 2014 Mar; 13():120. PubMed ID: 24674605
    [TBL] [Abstract][Full Text] [Related]  

  • 80. En-route to the 'elimination' of genotypic chloroquine resistance in Western and Southern Zambia, 14 years after chloroquine withdrawal.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Chizema-Kawesha E; Chipeta J; Lindtjørn B
    Malar J; 2019 Dec; 18(1):391. PubMed ID: 31796087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.